Rimonabant Review
Rimonabant is a weight loss product that was originally developed to be an aid for those trying to quit smoking. It was sold in Europe under the name Acomplia and has helped promote weight loss in the severely obese. Rimonabant is a product that has been produced by the same makers of the successful prescription products Ambien (a sleep aid) and Allegra (an anti-allergen). It is a confidence booster when a manufacturer has a history of quality products.
Pros
In some cases Rimonabant has proven to help users lose weight.
Cons
The Food and Drug Administration (FDA) of the United States has never approved this product for sale in the U.S. but the manufacturers of this product assure us that there is a patent pending. Patents are not the same as FDA approval, just for the record. Many of the countries where this product was originally approved for sale have since banned it citing the potential costs of Rimonabant outweigh the benefits. Sanofi-Aventis has since suspended the making of Rimonabant, but they held out for an extended period of time, and some have accused them of actually holding back negative study results, including severe depression in many cases in one study and at least one suicide. Previously named side effects included frequent and severe cases of depression, development of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, dependence, impairment of short term memory, etc.
Conclusion
The amount of negatives attributed to Rimonabant is not just vast; they are also infinitely more dangerous than a majority of the weight loss products you can find on the market at this time. This product has been banned in most of the world and its own manufacturers have stopped making it. This is not a product that you should even entertain the notion of trifling with. We do not recommend the purchase or use of Rimonabant.
Have you used Rimonabant?
Click Here to share your experience with others or Click Here to read Rimonabant customer reviews.